World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
EMD Serono at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
EMD Serono takes part in 6 sessions at World CDx 2026 in Boston. Its sessions center on liquid biopsy, from clinical guidelines, cost-effectiveness and reimbursement to its use in enrolling and monitoring trial patients. With Foundation Medicine, it traces the companion diagnostic path for TEPMETKO, which pairs a tissue test with a blood-based liquid biopsy.
| Organization | World CDx 2026 Attendance |
|---|---|
EMD Serono Rockland, MA | |
US and Canadian healthcare business of Merck KGaA, Darmstadt, developing medicines in oncology, neurology, immunology and fertility. | Talk Tue Oct 6 11:30am A Dual Tissue & Liquid Biopsy Strategy: The TEPMETKO® Companion Diagnostic Journey Clinical & companion diagnostic developmentLiquid biopsy & MRD Chair Wed Oct 7 8:00am Chair’s Opening Remarks Talk Wed Oct 7 11:50am Definition of the Best Practices in Clinical Utility of Liquid Biopsy: Clinical Guideline, Technologies, Cost-Effectiveness, Reimbursement, a Unidirectional or Multidirectional Path Liquid biopsy & MRDDrug–diagnostic commercialization & access Panel Wed Oct 7 12:50pm Transforming Patient Enrolment & Monitoring Through Innovation in Liquid Biopsy Analytes, Detection Sensitivity & Data Interpretation Liquid biopsy & MRD Chair Wed Oct 7 4:05pm Chair’s Opening Afternoon Remarks Chair Wed Oct 7 5:50pm Closing Remarks & End of Conference Day Two |
Instantly find 20 buyers from EMD Serono
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction